GS

Gulinder Singh

Active Director Director DIN 02920255
DIN 02920255 First appointment Feb 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 6 historical roles
Total affiliations 9 Since Feb 2010
Shareholding value •••• Premium profile

About Gulinder Singh

Data last updated:

Gulinder Singh is a Director at Medsea Healthcare Private Limited (since 2010), Director at Helios International Healthcare Private Limited (since 2019) and Director at Aventis Healthcare Private Limited (since 2012). The companies operate in Pharma, E-Commerce and Consumer Goods. The largest current company by reported revenue is Medsea Healthcare Private Limited at ₹2.03 Cr (FY 2024). Earlier, Gulinder Singh was a Director at Justmed Pharmacy Private Limited (2014–2023) and Director at Cobbler Shoes Bags Private Limited (2021–2022) and 4 more.

DIN 02920255
Primary Designation Director
Industry Pharma
First Appointment 11 Feb 2010
Oldest Company Age 16 yrs
Largest company Medsea Healthcare Private Limited · ₹2.03 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medsea Healthcare Private Limited U52100DL2010PTC198999
Director11 Feb 20102010₹2.03 Cr (FY 2024)Active
Director12 Jun 20192013Active
Aventis Healthcare Private Limited U24297DL2012PTC246189
Director14 Dec 20122012Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Justmed Pharmacy Private Limited U52300DL2014PTC265311
Director24 Feb 20142014₹61.7 Lakh (FY 2023)Active
Cobbler Shoes Bags Private Limited U52609DL2021PTC391079
Director10 Dec 20212021₹61 Lakh (FY 2025)Active
Magnus Biotech Private Limited U24231HR2003PTC035019
Director02 Jul 20182003₹16.13 Cr (FY 2025)Active
Royaltouch Spa Private Limited U74140DL2013PTC258722
Director04 Oct 20132013Strike Off
Director03 Sep 20122012Strike Off
Vellent Healthcare Private Limited U24233MH2021PTC367127
Director07 Sep 20212021Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Bio Aventis Healthcare Private Limited
Vellent Healthcare Private Limited
Aventis Healthcare Private Limited
Medsea Healthcare Private Limited
Premium access

Shareholding and investment profile for Gulinder Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gulinder Singh

Gulinder Singh currently holds 3 directorships: Medsea Healthcare Private Limited (Director, since 11 Feb 2010, revenue ₹2.03 Cr (FY 2024)); Helios International Healthcare Private Limited (Director, since 12 Jun 2019); Aventis Healthcare Private Limited (Director, since 14 Dec 2012).

Gulinder Singh was first appointed on 11 Feb 2010 as Director at Medsea Healthcare Private Limited. The most recent appointment on record is 10 Dec 2021 at Cobbler Shoes Bags Private Limited.

Gulinder Singh held 6 earlier board appointments: Justmed Pharmacy Private Limited (Director, 24 Feb 2014 to 24 Mar 2023); Cobbler Shoes Bags Private Limited (Director, 10 Dec 2021 to 11 May 2022); Magnus Biotech Private Limited (Director, 02 Jul 2018 to 10 Aug 2022); Royaltouch Spa Private Limited (Director, 04 Oct 2013 to 01 Nov 2014); Bio Aventis Healthcare Private Limited (Director, from 03 Sep 2012); and 1 more.

The current boards of Gulinder Singh's companies include Popinder Kaur (Medsea Healthcare Private Limited), Tajinder Singh (Helios International Healthcare Private Limited), Tanwant Singh Malhotra (Helios International Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available